Outcomes of infected cardiovascular implantable devices in dialysis patients
- PMID: 25323128
- PMCID: PMC4216629
- DOI: 10.1159/000366453
Outcomes of infected cardiovascular implantable devices in dialysis patients
Abstract
Background/aims: Dialysis patients are at a higher risk for cardiovascular implantable electronic device (CIED) infection-related hospitalizations. We compared the outcomes and cost for dialysis and non-dialysis patients hospitalized with CIED infections.
Methods: We conducted a retrospective analysis of the Nationwide Inpatient Sample (NIS) discharge records from 2005 to 2010. Patients with CIED infections were identified using ICD-9 codes for device-related infections or device procedure along with bacteremia, endocarditis or systemic infection. Dialysis patients were identified using ICD-9 codes. Multivariable logistic and linear regressions were performed to examine in-hospital mortality, length of stay and cost.
Results: Of the 87,798 estimated hospitalizations with CIED infections, 6,665 (7.6%) were dialysis patients. CIED-infection-related hospitalization has increased over time among dialysis patients. In-hospital mortality was higher among dialysis patients (13.6% vs. 5.9%, p < 0.001). In the multivariable model, dialysis patients had higher odds of in-hospital mortality (odds ratio 1.98; 95% CI: 1.6, 2.4) compared to the non-dialysis group. Dialysis patients had a longer median length of stay (12 days vs. 7 days, p < 0.001) and majority required extended care facility upon discharge (51.2% vs. 35.0%, p < 0.001) compared to the non-dialysis group. Dialysis status was associated with 50.3% increased cost of hospitalization (p < 0.001).
Conclusion: CIED-infection related hospitalization is increasing among patients undergoing dialysis and is associated with higher in-hospital mortality, longer hospital stay and higher costs of hospitalization. Future studies should examine the reasons for such a high risk and find means to improve outcomes in dialysis population.
© 2014 S. Karger AG, Basel.
Figures
Similar articles
-
Thrombocytopenia and end stage renal disease are key predictors of survival in patients with cardiac implantable electronic device infections.J Cardiovasc Electrophysiol. 2020 Jan;31(1):70-79. doi: 10.1111/jce.14270. Epub 2019 Nov 20. J Cardiovasc Electrophysiol. 2020. PMID: 31702855
-
Cardiac implantable electronic device infection in patients with end-stage renal disease.Heart Rhythm. 2015 Dec;12(12):2395-401. doi: 10.1016/j.hrthm.2015.08.003. Epub 2015 Aug 4. Heart Rhythm. 2015. PMID: 26253036
-
Comparison of mortality in women versus men with infections involving cardiovascular implantable electronic device.Am J Cardiol. 2013 Nov 1;112(9):1403-9. doi: 10.1016/j.amjcard.2013.06.031. Epub 2013 Aug 22. Am J Cardiol. 2013. PMID: 23972346
-
Transvenous cardiac implantable electronic devices and hemodialysis catheters: recommendations to curtail a potentially lethal combination.Semin Dial. 2012 Sep-Oct;25(5):582-6. doi: 10.1111/j.1525-139X.2012.01053.x. Epub 2012 Feb 22. Semin Dial. 2012. PMID: 22353033 Review.
-
Prevention, Diagnosis, and Treatment of Cardiac Implantable Electronic Device Infections.Curr Cardiol Rep. 2016 Jun;18(6):58. doi: 10.1007/s11886-016-0733-x. Curr Cardiol Rep. 2016. PMID: 27147510 Review.
Cited by
-
Cardiac Implantable Electronic Device Infections in Patients with Renal Insufficiency: A Systematic Review and Meta-Analysis.Diseases. 2024 Oct 10;12(10):247. doi: 10.3390/diseases12100247. Diseases. 2024. PMID: 39452490 Free PMC article. Review.
-
Do Implantable Cardioverter-Defibrillators Prevent Sudden Cardiac Death in End-Stage Renal Disease Patients on Dialysis?J Clin Med. 2024 Feb 19;13(4):1176. doi: 10.3390/jcm13041176. J Clin Med. 2024. PMID: 38398488 Free PMC article. Review.
-
Device-related infection and mortality in patients with chronic kidney disease receiving cardiac implantable electronic devices: a propensity score-matched cohort study.BMC Infect Dis. 2023 Nov 13;23(1):787. doi: 10.1186/s12879-023-08773-0. BMC Infect Dis. 2023. PMID: 37957553 Free PMC article.
-
The cardiovascular-dialysis nexus: the transition to dialysis is a treacherous time for the heart.Eur Heart J. 2021 Mar 31;42(13):1244-1253. doi: 10.1093/eurheartj/ehaa1049. Eur Heart J. 2021. PMID: 33458768 Free PMC article. Review.
-
Implantable Cardioverter-Defibrillators in Patients with ESRD: Complications, Management, and Literature Review.Curr Cardiol Rev. 2019;15(3):161-166. doi: 10.2174/1573403X15666190118123754. Curr Cardiol Rev. 2019. PMID: 30657044 Free PMC article. Review.
References
-
- Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, Lewis J, Rocco M, Toto R, Windus D, Ornt D, Levey AS HEMO Study Group. Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO study. Kidney Int. 2004;65(6):2380–2389. - PubMed
-
- Stack AG, Bloembergen WE. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the united states: A cross-sectional study. J Am Soc Nephrol. 2001;12(7):1516–1523. - PubMed
-
- Shamseddin MK, Parfrey PS. Sudden cardiac death in chronic kidney disease: Epidemiology and prevention. Nat Rev Nephrol. 2011;7(3):145–154. - PubMed
-
- Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47(1):186–192. - PubMed
-
- USRDS. Atlas of CKD & ESRD. 2013;2013(December 12)
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
